Response to Wang et al., “Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial”
Journal of the American Academy of Dermatology · 2024
DOI: 10.1016/j.jaad.2023.08.113 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2024. Verfasst von John Sauer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey. Electronic address: sauerj62@rowan.edu. Hauptthemen laut MEDLINE: Paroxetine, Rosacea. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey. Electronic address: sauerj62@rowan.edu.
- Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey.
Zitieren
APA
Sauer, J., & Zanghi, N. (2024). Response to Wang et al., “Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial”. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.08.113
Vancouver
Sauer J, Zanghi N. Response to Wang et al., “Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial”. Journal of the American Academy of Dermatology. 2024. doi:10.1016/j.jaad.2023.08.113
BibTeX
@article{Sauer2024,
author = {Sauer, John and Zanghi, Nicholas},
title = {Response to Wang et al., “Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial”},
journal = {Journal of the American Academy of Dermatology},
year = {2024},
doi = {10.1016/j.jaad.2023.08.113}
}
EUVIMED